Korro Bio, Inc. Increase (Decrease) in Accrued Liabilities
Korro Bio, Inc. (KRRO) reported Increase (Decrease) in Accrued Liabilities of -$2.52 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-06
- Korro Bio, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$2.32M, a 215.73% decline year-over-year.
- Korro Bio, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$205.00K.
- Korro Bio, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $1.75M, a 119.85% increase year-over-year.
- Korro Bio, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $189.00K.
- Korro Bio, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was $1.43M.
- Korro Bio, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$3.97M, a 412.52% decline from fiscal 2023.
- Korro Bio, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $1.27M.
- Korro Bio, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was -$39.00K.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 6 month as first filed | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 9 month as first filed | Increase (Decrease) in Accrued Liabilities 12 month | Increase (Decrease) in Accrued Liabilities 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$2.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.52M 10-Q · filed 2026-08-06 | -$773.00K derived: sum of 3 quarters · filed 2026-08-06 | -$584.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | -$205.00K 10-Q · filed 2026-05-07 | $1.54M derived: sum of 2 quarters · filed 2026-05-07 | $1.73M derived: sum of 3 quarters · filed 2026-05-07 | $3.74M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $1.75M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $1.94M derived: sum of 2 quarters · filed 2026-03-12 | $3.94M derived: sum of 3 quarters · filed 2026-08-06 | $1.43M 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | $189.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $2.19M derived: sum of 2 quarters · filed 2026-08-06 | -$319.00K 10-Q · filed 2025-11-12 | $477.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $2.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$508.00K 10-Q · filed 2026-08-06 | $288.00K derived: sum of 3 quarters · filed 2026-08-06 | -$428.00K derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | -$2.51M 10-Q · filed 2026-05-07 | -$1.72M derived: sum of 2 quarters · filed 2026-05-07 | -$2.43M derived: sum of 3 quarters · filed 2026-05-07 | -$1.43M derived: sum of 4 quarters · filed 2026-05-07 | ||||
| 2024-12-31 | $796.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $80.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.08M derived: sum of 3 quarters · filed 2026-03-12 | -$3.97M 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$716.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $283.00K derived: sum of 2 quarters · filed 2025-11-12 | -$4.76M 10-Q · filed 2025-11-12 | -$5.22M derived: sum of 4 quarters · filed 2025-11-12 | ||||
| 2024-06-30 | $999.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$4.05M 10-Q · filed 2025-08-12 | -$4.51M derived: sum of 3 quarters · filed 2025-08-12 | -$2.56M derived: sum of 4 quarters · filed 2025-08-12 | ||||
| 2024-03-31 | -$5.05M 10-Q · filed 2025-05-07 | -$5.51M derived: sum of 2 quarters · filed 2025-05-07 | -$3.56M derived: sum of 3 quarters · filed 2025-05-07 | -$2.66M derived: sum of 4 quarters · filed 2025-05-07 | ||||
| 2023-12-31 | -$460.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | $1.49M derived: sum of 2 quarters · filed 2025-03-18 | $2.39M derived: sum of 3 quarters · filed 2025-03-18 | $1.27M 10-K · filed 2025-03-18 | ||||
| 2023-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $2.85M derived: sum of 2 quarters · filed 2024-11-12 | $1.73M 10-Q · filed 2024-11-12 | $2.19M 10-Q · filed 2023-11-02 | $2.09M derived: sum of 4 quarters · filed 2024-11-12 | |||
| 2023-06-30 | $896.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$221.00K 10-Q · filed 2024-08-13 | -$782.00K 10-Q · filed 2023-08-10 | $136.00K derived: sum of 3 quarters · filed 2024-08-13 | $361.00K derived: sum of 4 quarters · filed 2024-08-13 | |||
| 2023-03-31 | -$1.12M 10-Q · filed 2024-05-14 | -$413.00K 10-Q · filed 2023-05-12 | -$760.00K derived: sum of 2 quarters · filed 2024-05-14 | -$535.00K derived: sum of 3 quarters · filed 2024-05-14 | $196.00K derived: sum of 4 quarters · filed 2024-05-14 | |||
| 2022-12-31 | $357.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $582.00K derived: sum of 2 quarters · filed 2024-03-26 | $1.31M derived: sum of 3 quarters · filed 2024-03-26 | -$39.00K 10-K · filed 2024-03-26 | -$208.00K 10-K · filed 2023-03-10 | |||
| 2022-09-30 | $225.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $956.00K derived: sum of 2 quarters · filed 2023-11-02 | -$396.00K 10-Q · filed 2023-11-02 | $408.00K derived: sum of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | $731.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$621.00K 10-Q · filed 2023-08-10 | $183.00K derived: sum of 3 quarters · filed 2023-08-10 | $1.75M derived: sum of 4 quarters · filed 2023-08-10 | ||||
| 2022-03-31 | -$1.35M 10-Q · filed 2023-05-12 | -$548.00K derived: sum of 2 quarters · filed 2023-05-12 | $1.02M derived: sum of 3 quarters · filed 2023-05-12 | $2.28M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $804.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-10 | $2.37M derived: sum of 2 quarters · filed 2023-03-10 | $3.63M derived: sum of 3 quarters · filed 2023-03-10 | -$398.00K 10-K · filed 2023-03-10 | -$794.00K 10-K · filed 2022-03-15 | |||
| 2021-09-30 | $1.57M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $2.83M derived: sum of 2 quarters · filed 2022-11-08 | -$1.20M 10-Q · filed 2022-11-08 | $1.01M derived: sum of 4 quarters · filed 2022-11-08 | ||||
| 2021-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | -$2.77M 10-Q · filed 2022-08-09 | -$558.00K derived: sum of 3 quarters · filed 2022-08-09 | $433.00K derived: sum of 4 quarters · filed 2022-08-09 | ||||
| 2021-03-31 | -$4.03M 10-Q · filed 2022-05-04 | -$1.82M derived: sum of 2 quarters · filed 2022-05-04 | -$828.00K derived: sum of 3 quarters · filed 2022-05-04 | $369.00K derived: sum of 4 quarters · filed 2022-05-04 | ||||
| 2020-12-31 | $2.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $3.21M derived: sum of 2 quarters · filed 2022-03-15 | $4.40M derived: sum of 3 quarters · filed 2022-03-15 | $3.08M 10-K · filed 2022-03-15 | ||||
| 2020-09-30 | $991.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $2.19M derived: sum of 2 quarters · filed 2021-11-15 | $869.00K 10-Q · filed 2021-11-15 | $892.00K derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | $1.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | -$122.00K 10-Q · filed 2021-08-12 | -$99.00K derived: sum of 3 quarters · filed 2021-08-12 | $625.00K derived: sum of 4 quarters · filed 2021-08-12 | ||||
| 2020-03-31 | -$1.32M 10-Q · filed 2021-05-13 | -$1.30M derived: sum of 2 quarters · filed 2021-05-13 | -$572.00K derived: sum of 3 quarters · filed 2021-05-13 | $654.00K derived: sum of 4 quarters · filed 2021-05-13 | ||||
| 2019-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $747.00K derived: sum of 2 quarters · filed 2021-03-29 | $1.97M derived: sum of 3 quarters · filed 2021-03-29 | $1.49M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $724.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $1.95M derived: sum of 2 quarters · filed 2020-11-16 | $1.47M 10-Q · filed 2020-11-16 | |||||
| 2019-06-30 | $1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | $743.00K 10-Q · filed 2020-08-12 | ||||||
| 2019-03-31 | -$483.00K 10-Q · filed 2020-05-14 | |||||||
| 2018-12-31 | $677.00K 10-K · filed 2020-03-26 | |||||||
| 2017-12-31 | $365.00K 10-K · filed 2020-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |